# We-Linking

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/we-linking

- Industry: Healthcare IT
- Headquarters: Shenzhen, China
- Website: www.we-linking.com
- Latest round: Angel (Nov 1, 2023)
- Investors on record: 7

## About

Based in Guangdong, China, and founded in 2019, Shenzhen Weiling Medical Technology Co., Ltd., trading as We-Linking, is a medical equipment company focusing on full-chain autonomous technology for implantable brain-computer interfaces. It has set up an R&D center in Shenzhen, clinical research and data centers in Beijing and Suzhou, and a North American branch in Maryland, USA. The founder, Xiaojian Xiao, is a senior engineer and doctoral supervisor of the Chinese Academy of Sciences Shenzhen Institute of Advanced Technology and Shenzhen Hong Kong Institute of Brain Science Innovation. In August 2026, We-Linking raised over CNY 100 million in venture funding led by Junzhong Capital, with participation from Innovita Biological Technology Co., Ltd.

The company focuses on the clinical solution design, engineering implementation, and clinical practice of a fully implantable motor brain-computer interface system. We-Linking has completed the development of basic hardware and software systems for the full stack of brain-computer interfaces. Its core components include neural sensor arrays, acquisition and stimulation of an integrated closed-loop neuroelectronic chip, miniaturized brain-computer information interactors, and wireless transceivers for brain information. The products can serve a group of motor disability patients such as stroke, spinal cord injury, and frostbite. 

The company's revenue is generated by providing medical-grade fully implantable wireless brain-computer interface systems.

The company will use the latest funding to advance the clinical validation of core implantable brain-computer interface products, accelerate the medical device registration and application process, improve the manufacturing system, and continuously expand its clinical application layout in the field of neurofunctional repair.

## Funding rounds

- Angel, Nov 1, 2023 — CDH Investments, Gaorong Ventures, Lccap, Together To Miracle
- Angel, Mar 21, 2023 — CDH Investments, Lanchi Ventures, Beijing Naton Technology Group Co.,ltd., Future Light Cone

## Investors

- CDH Investments (https://capitalatlas.ai/funds/cdh-investments) — Angel
- Lanchi Ventures (https://capitalatlas.ai/funds/lanchi-ventures) — Angel
- Beijing Naton Technology Group Co.,ltd. — Angel
- Future Light Cone — Angel
- Gaorong Ventures (https://capitalatlas.ai/funds/gaorong-ventures) — Angel
- Lccap — Angel
- Together To Miracle — Angel